UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
When redeeming rewards, several factors can influence your choices. Learn what to consider to ensure you get the best value for your points.
17,005 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
A 64-year-old executive faces a year of severance after a sudden layoff and chooses to claim Social Security at 64. T...
As a looming recession tests crypto narratives, Bitcoin’s fixed supply and growing institutional interest face off ag...
When a Harmonic director sold 4,300 shares, it sparked questions about the stock’s outlook. This guide breaks down in...
As investors eye the next earnings cycle, corvel (crvl) 2026 earnings take center stage. This article breaks down bus...
Bond yields jumped to the mid-4% range on the benchmark 10-year, nudging investors to re-evaluate risk. Research Affi...
In a year of volatile rates, Vanguard’s cheapest short-term bond ETF stands out for ultra-low fees and solid near-ter...
A new industry report shows on-time flight arrivals at their worst since 2014, pushed by higher fuel costs and volati...
Rocket Mortgage and Rocket Pro are rolling out VantageScore 4.0 in the mortgage qualification process, pairing it wit...
In a higher-rate environment, CDL continues to deliver a reliable monthly cash stream with a $2.29 per-share annual d...
A concentrated AI-focused fund with a heavy tilt to Alphabet has surged as demand for AI infrastructure and software ...
Retirees facing rising taxes must plan withdrawals carefully. With $2M in retirement accounts, a strategic advisor ca...